Microbix Biosystms (MBX) Stock Statistics & Valuation Metrics

Microbix Biosystms has a market cap or net worth of C$41.47M. The enterprise value is C$31.57M.

Microbix Biosystms has 140,561,450 shares outstanding. The number of shares has decreased by -2.65% in one year.

Microbix Biosystms’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 10.72%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Microbix Biosystms had revenue of 25.39M and earned 3.52M in profits. Earnings per share was 0.03.

In the last 12 months, operating cash flow was 3.93M and capital expenditures -1.68M, giving a free cash flow of 2.25M billion.

Microbix Biosystms pays an annual dividend of ―, resulting in a dividend yield of ―

Microbix Biosystms upcoming earnings date is Aug 13, 2025, TBA (Confirmed).

Microbix Biosystms as a current ratio of 7.15, with Debt / Equity ratio of 17.22%

In the past 12 months, Microbix Biosystms has paid 150.56K in taxes.

Microbix Biosystms EV to EBITDA ratio is 6.32, with an EV/FCF ratio of 16.07.

Microbix Biosystms has C$14.54M in cash and marketable securities with C$5.35M in debt, giving a net cash position of -C$9.19M billion.

Gross margin is 57.74%, with operating margin of 15.38%, and net profit margin of 13.86%.

The average price target for Microbix Biosystms is C$0.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy